MichaelJFisherMD

Pediatric Hematology & Oncology • Philadelphia, PA

Pediatric Neuro-Oncology

Associate Professor, Pediatrics, Perelman School of Medicine

Overview of Dr. Fisher

Dr. Michael Fisher is a pediatric hematologist/oncologist in Philadelphia, PA and is affiliated with Children's Hospital of Philadelphia. He received his medical degree from Harvard Medical School and has been in practice 23 years. Dr. Fisher accepts several types of health insurance, listed below. He is one of 160 doctors at Children's Hospital of Philadelphia who specialize in Pediatric Hematology & Oncology. He has more than 100 publications and over 500 citings.

Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Hem/Onc
Philadelphia, PA 19104
Book by Phone+1(267) 692-8712

Fax+1 215-590-3992
Is this information wrong?

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1994 - 1997
Harvard Medical SchoolClass of 1994

Certifications & Licensure

PA State Medical License 1997 - 2024
NY State Medical License 2018 - 2020
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma Start of enrollment: 2002 Apr 01
Terminated
Not Applicable
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas Start of enrollment: 2008 Jul 01
Terminated
Phase 1
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Start of enrollment: 2012 Dec 13
Active, not recruiting
Phase 2
MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 Start of enrollment: 2014 Jun 01
Completed
Phase 2
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults Start of enrollment: 2014 Jun 01
Completed
Phase 2
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Start of enrollment: 2018 Aug 01
Active, not recruiting
Phase 1
Roles: Principal Investigator, Contact
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Start of enrollment: 2021 Apr 08
Recruiting
Early Phase 1
Roles: Contact
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2023 Apr 10
Recruiting
Phase 2
Roles: Contact
A Phase II Trial of Poly-ICLC for Low-Grade Gliomas Start of enrollment: 2021 Dec 15
Recruiting
Phase 2
Roles: Contact
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas Start of enrollment: 2024 Jun 15
Not yet recruiting
Phase 2
Roles: Contact
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2022 Dec 16
Recruiting
Phase 2
Roles: Contact
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma Start of enrollment: 2024 Apr 15
Not yet recruiting
Phase 2
Roles: Contact, Principal Investigator
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors Start of enrollment: 2022 Nov 21
Recruiting
Phase 1, Phase 2
Roles: Contact
Targeted Pediatric High-Grade Glioma Therapy Start of enrollment: 2024 May 30
Not yet recruiting
Roles: Contact
Study of Ribociclib and Everolimus in HGG and DIPG Start of enrollment: 2024 May 30
Not yet recruiting
Phase 2
Roles: Contact
Study of Olutasidenib and Temozolomide in HGG Start of enrollment: 2024 Jun 01
Not yet recruiting
Phase 2
Roles: Study Chair, Contact
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion Start of enrollment: 2024 Sep 01
Not yet recruiting
Early Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by th...
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay, Peter de Blank, Roger J Packer, Maryam Fouladi, Antoinette Schouten van Mee...> ;Neuro-Oncology. 2024 Mar 4
Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
Jason Fangusaro, David T Jones, Roger J Packer, Till Milde, Olaf Witt, Sabine Mueller, Jordan R Hansford, Uri Tabori, Darren Hargrave, Pratiti Bandopadhayay, Gutmann, ...> ;Neuro-Oncology. 2024 Jan 5
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
Liny John, Gurbani Singh, Eva Dombi, Pamela L Wolters, Staci Martin, Andrea Baldwin, Seth M Steinberg, Jessica Bernstein, Patricia Whitcomb, Dominique C Pichard, Anne ...> ;Clinical Trials. 2024 Apr 1
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analy...
Chelsea Kotch, Stephanie J Si, Kavita Desai, Philippe Caminada, Francesco Maria Lo Russo, Yimei Li, Grant T Liu, Robert A Avery, Michael J Fisher> ;Journal of Neuro-Oncology. 2023 Sep 1
6 citations
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
Andrea M Gross, Eva Dombi, Pamela L Wolters, Andrea Baldwin, Anne Dufek, Kailey Herrera, Staci Martin, Joanne Derdak, Kara S Heisey, Patricia M Whitcomb, Seth M Steinb...> ;Neuro-Oncology. 2023 Oct 3
1 citations
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.
Andrea M Gross, Scott R Plotkin, Nelson B Watts, Michael J Fisher, Laura J Klesse, Andrés J Lessing, Miranda L McManus, A Noelle Larson, Beverly Oberlander, Jonathan J...> ;Clinical Trials. 2024 Feb 1
2 citations
Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.
Till Milde, Jason Fangusaro, Michael J Fisher, Cynthia Hawkins, Fausto J Rodriguez, Uri Tabori, Olaf Witt, Yuan Zhu, Gutmann, D. H., Gutmann, D. H., David H Gutmann> ;Neuro-Oncology. 2023 Nov 2
Adverse cutaneous reactions associated with MEK inhibitor therapy in a pediatric population.
Fahad Ahmed, Michael J Fisher, Kristen M Snyder, Katherine Smith, Benjamin L Laskin, Marissa J Perman> ;Journal of the American Academy of Dermatology. 2023 Nov 1
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1.
Chelsea Kotch, Eva Dombi, Amish C Shah, Katherine Smith, Symone Brown, Yimei Li, Brigitte C Widemann, Michael J Fisher> ;The Journal of Pediatrics. 2023 Sep 1
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.
Chelsea Kotch, Kristina Wagner, J Harris Broad, Eva Dombi, Jane E Minturn, Peter Phillips, Katherine Smith, Yimei Li, Ian N Jacobs, Lisa M Elden, Michael J Fisher, Jea...> ;Cancers. 2023 May 5
2 citations
Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2.
Chelsea Kotch, Stephanie Nicole Brosius, Thomas De Raedt, Michael Jay Fisher> ;Pediatric Neurosurgery. 2023 Jan 1
4 citations
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medic...
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, Caroline Hutter, Olaf Witt, Susan Weiner, Gregory Reaman, Mark Russo, Pratiti Bandopadhayay, Sama Ahsan, Amy Barone, El...> ;European Journal of Cancer. 2022 Dec 1
4 citations
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, Eva Dombi, Andrea Baldwin, Michael J Fisher, AeRang Kim, Miriam Bornhorst, Brian D Weiss, Jaishri O Blakeley, Pat...> ;Neuro-Oncology. 2022 Nov 2
2 citations
Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
Stephanie N Brosius, Arastoo Vossough, Michael J Fisher, Shih-Shan Lang, Lauren A Beslow, Brandon J George, Rebecca Ichord> ;Pediatric Neurology. 2022 Sep 1
6 citations
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.
Chelsea Kotch, Robert Avery, Kelly D Getz, Eric Bouffet, Peter de Blank, Robert Listernick, David H Gutmann, Miriam Bornhorst, Cynthia Campen, Grant T Liu, Richard Apl...> ;Neuro-Oncology. 2022 Aug 1
24 citations
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag, Ashley Cannon, Eva Dombi, Jason Fangusaro, Bruce D Gelb, Darren Hargrave,...> ;Neuro-Oncology. 2022 Nov 2
60 citations
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Scott R Plotkin, Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A Avery, Jaishri O Blakeley, Dusica Babovic-Vuksanovic, Rosalie Ferner, Michael J Fisher, Jan M ...> ;Genetics in Medicine. 2022 Sep 1
24 citations
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Michael J Fisher, Jaishri O Blakeley, Brian D Weiss, Eva Dombi, Shivani Ahlawat, Srivandana Akshintala, Allan J Belzberg, Miriam Bornhorst, Miriam A Bredella, Wenli Ca...> ;Neuro-Oncology. 2022 Nov 2
Introduction. Evolving perspectives on the intersection between neurosurgery and neurocutaneous disorders.
Caitlin E Hoffman, Ramesh Sharanappa Doddamani, Michael J Fisher, Howard L Weiner> ;Neurosurgical Focus. 2022 May 1
2 citations
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis.
Chelsea Kotch, Michael J Fisher, Fumin Lin, Yiming Zhong, Dan Gallo, Zhiqian Fan, Jiani Chen, Mariarita Santi, Marilyn M Li> ;Cancer Genetics. 2022 Apr 1
Comparison of Visual Acuity Results Between ATS-HOTV and E-ETDRS Testing Methods in Children With Optic Pathway Gliomas.
Robert A Avery, Cammille Go, Michael J Fisher, Grant T Liu, Arielle Garcia, Meg Richter, Brendan McGeehan, Graham E Quinn, Gui-Shuang Ying> ;Translational Vision Science & Technology. 2022 Mar 2
55 citations
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Anthony P. Y. Liu, Kyle S. Smith, Rahul Kumar, Leena Paul, Laure Bihannic, Tong Lin, Kendra K. Maass, Kristian W. Pajtler, Murali Chintagumpala, Jack Su, Eric Bouffet,...> ;Cancer Cell. 2021 Nov 8
8 citations
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
Lauren Walker, Richard Fitzgerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Karen Martin, Izabela Eberhart, Christie Woods, Sean Ewings, Colin Hale, Rajith K. ...> ;Clinical Pharmacology and Therapeutics. 2021 Oct 26
2 citations
Arterial spin labeling as an ancillary assessment to postoperative conventional angiogram in pediatric moyamoya disease.
Shih-Shan Lang, Alexander M. Tucker, Craig Schreiber, Phillip B. Storm, Hongyan Liu, Yimei Li, Rebecca Ichord, Lauren A. Beslow, Neda I. Sedora-Roman, Mougnyan Cox, Hu...> ;Journal of Neurosurgery. Pediatrics. 2021 Oct 1
4 citations
A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.
Jane E. Minturn, Aaron Y Mochizuki, Sonia Partap, Jean B. Belasco, Beverly J. Lange, Yimei Li, Peter C. Phillips, Iris C. Gibbs, Paul G. Fisher, Michael Fisher, Anna J...> ;Frontiers in Oncology. 2021 Sep 2
Join now to see all

Press Mentions

High Court Allows Employers to Opt Out of ACA’s Mandate on Birth Control CoverageJuly 9th, 2020
High Court Allows Employers to Opt Out of ACA’s Mandate on Birth Control CoverageJuly 8th, 2020

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
AmeriHealth Direct POS Value Network
Amerihealth HMO
AmeriHealth HMO Value Network
AmeriHealth PPO
AmeriHealth PPO Value Network
BCBS Blue Card PPO
BCBS Tennessee Network 5
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
First Health PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Horizon BCBS Direct Access
Horizon BCBS HMO
Horizon BCBS POS
Horizon BCBS PPO
Humana ChoiceCare Network PPO
Humana/ChoiceCare+ Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment